| Stage | CHRW | % of rev | BCO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.4B | 100.00% | $1.4B | 100.00% | CHRW ×3.90 |
| Gross profit | $448M | 8.36% | $334M | 24.32% | BCO +16.0pp |
| Operating income | $272M | 5.07% | $131M | 9.53% | BCO +4.5pp |
| Pre-tax income | $250M | 4.67% | $40M | 2.93% | CHRW +1.7pp |
| Net income | $198M | 3.70% | $17M | 1.20% | CHRW +2.5pp |
| Stage | CHRW | BCO | Gap · A − B |
|---|---|---|---|
| Revenue | $5.4B100.00% | $1.4B100.00% | CHRW ×3.90 |
| Gross profit | 8.36%$448M | 24.32%$334M | BCO +16.0pp |
| Operating income | 5.07%$272M | 9.53%$131M | BCO +4.5pp |
| Pre-tax income | 4.67%$250M | 2.93%$40M | CHRW +1.7pp |
| Net income |
| 3.70%$198M |
| 1.20%$17M |
| CHRW +2.5pp |
No disclosed counterparties: CHRW, BCO.